Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


12.06.2017

1 Ann Neurol
1 BMC Neurol
2 BMC Neurosci
2 J Biol Chem
1 J Neural Transm (Vienna)
2 J Neurol Neurosurg Psychiatry
1 J Neurosci
11 Mov Disord
1 Nat Rev Neurosci
1 Neurobiol Dis
2 Neurology
1 Neuropsychology
2 Neurosci Lett
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. HORN A, Reich M, Vorwerk J, Li N, et al
    Connectivity predicts deep brain stimulation outcome in Parkinson's disease.
    Ann Neurol. 2017 Jun 6. doi: 10.1002/ana.24974.
    PubMed     Text format     Abstract available


    BMC Neurol

  2. MO JJ, Liu LY, Peng WB, Rao J, et al
    The effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trials.
    BMC Neurol. 2017;17:105.
    PubMed     Text format     Abstract available


    BMC Neurosci

  3. CHIANG PL, Chen HL, Lu CH, Chen PC, et al
    White matter damage and systemic inflammation in Parkinson's disease.
    BMC Neurosci. 2017;18:48.
    PubMed     Text format     Abstract available

  4. SINGH P, Hanson PS, Morris CM
    SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson's disease.
    BMC Neurosci. 2017;18:46.
    PubMed     Text format     Abstract available


    J Biol Chem

  5. YOSHIMURA Y, Holmberg MA, Kukic P, Andersen CB, et al
    MOAG-4 promotes the aggregation of alpha-synuclein by competing with self-protective electrostatic interactions.
    J Biol Chem. 2017;292:8269-8278.
    PubMed     Text format     Abstract available

  6. DHAVALE DD, Tsai C, Bagchi DP, Engel LA, et al
    A sensitive assay reveals structural requirements for alpha-synuclein fibril growth.
    J Biol Chem. 2017;292:9034-9050.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  7. NOBIS L, Schindlbeck K, Ehlen F, Tiedt H, et al
    Theory of mind performance in Parkinson's disease is associated with motor and cognitive functions, but not with symptom lateralization.
    J Neural Transm (Vienna). 2017 Jun 5. doi: 10.1007/s00702-017-1739.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  8. NISHIO Y, Yokoi K, Uchiyama M, Mamiya Y, et al
    Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 9. pii: jnnp-2017-315741.
    PubMed     Text format     Abstract available

  9. NOYCE AJ, Schrag A, Masters JM, Bestwick JP, et al
    Subtle motor disturbances in PREDICT-PD participants.
    J Neurol Neurosurg Psychiatry. 2017;88:212-217.
    PubMed     Text format     Abstract available


    J Neurosci

  10. ORTNER NJ, Bock G, Dougalis A, Kharitonova M, et al
    Lower affinity of isradipine for L-type Ca2+ channels during substantia nigra dopamine neuron-like activity: implications for neuroprotection in Parkinson's disease.
    J Neurosci. 2017 Jun 7. pii: 2946-16. doi: 10.1523/JNEUROSCI.2946-16.2017.
    PubMed     Text format     Abstract available


    Mov Disord

  11. KUMAR A
    Reprogramming the striatal stars: A new treatment option for Parkinson's disease.
    Mov Disord. 2017 Jun 7. doi: 10.1002/mds.27067.
    PubMed     Text format    

  12. QUATTRONE A, Nigro S
    MRI measures of brainstem in Parkinsonian syndromes: Where we stand and where we need to go.
    Mov Disord. 2017 Jun 7. doi: 10.1002/mds.27056.
    PubMed     Text format    

  13. MAHLKNECHT P, Akram H, Georgiev D, Tripoliti E, et al
    Pyramidal tract activation due to subthalamic deep brain stimulation in Parkinson's disease.
    Mov Disord. 2017 Jun 7. doi: 10.1002/mds.27042.
    PubMed     Text format     Abstract available

  14. PINA-FUENTES D, Little S, Oterdoom M, Neal S, et al
    Adaptive DBS in a Parkinson's patient with chronically implanted DBS: A proof of principle.
    Mov Disord. 2017 Jun 7. doi: 10.1002/mds.26959.
    PubMed     Text format    

  15. MEROLA A, Rosso M, Romagnolo A, Comi C, et al
    Peripheral neuropathy as marker of severe Parkinson's disease phenotype.
    Mov Disord. 2017 May 8. doi: 10.1002/mds.27025.
    PubMed     Text format    

  16. KASSUBEK J, Huppertz HJ, Hoglinger GU
    Reply to: MRI measures of brainstem in parkinsonian syndromes: Where we stand and where we need to go.
    Mov Disord. 2017 Jun 7. doi: 10.1002/mds.27057.
    PubMed     Text format    

  17. ROSSI A, Berger K, Chen H, Leslie D, et al
    Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.
    Mov Disord. 2017 Jun 7. doi: 10.1002/mds.27063.
    PubMed     Text format     Abstract available

  18. LARSSON SC, Singleton AB, Nalls MA, Richards JB, et al
    No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.
    Mov Disord. 2017 Jun 8. doi: 10.1002/mds.27069.
    PubMed     Text format     Abstract available

  19. LENKA A, Pal PK
    "Miro" in Parkinson's disease: Here, there, everywhere!
    Mov Disord. 2017;32:839.
    PubMed     Text format    

  20. VAILLANCOURT DE
    What Would Dr. James Parkinson Think Today? Tau and Other Imaging Possibilities in Parkinson's Disease.
    Mov Disord. 2017;32:805-806.
    PubMed     Text format    

  21. AKRAM H, Wu C, Hyam J, Foltynie T, et al
    l-Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson's disease.
    Mov Disord. 2017;32:874-883.
    PubMed     Text format     Abstract available


    Nat Rev Neurosci

  22. SCHAPIRA AHV, Chaudhuri KR, Jenner P
    Non-motor features of Parkinson disease.
    Nat Rev Neurosci. 2017 Jun 8. doi: 10.1038/nrn.2017.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  23. GIESERT F, Glasl L, Zimprich A, Ernst L, et al
    The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.
    Neurobiol Dis. 2017 May 30. pii: S0969-9961(17)30123.
    PubMed     Text format     Abstract available


    Neurology

  24. HUGHES KC, Gao X, Kim IY, Wang M, et al
    Intake of dairy foods and risk of Parkinson disease.
    Neurology. 2017 Jun 8. pii: 10.1212/WNL.0000000000004057.
    PubMed     Text format     Abstract available

  25. RAJPUT AH, Rajput ML, Ferguson LW, Rajput A, et al
    Baseline motor findings and Parkinson disease prognostic subtypes.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004078.
    PubMed     Text format     Abstract available


    Neuropsychology

  26. LUNDQVIST D, Svard J, Michelgard Palmquist A, Fischer H, et al
    Patients With Parkinson's Disease Display a Dopamine Therapy Related Negative Bias and an Enlarged Range in Emotional Responses to Facial Emotional Stimuli.
    Neuropsychology. 2017 Jun 5. doi: 10.1037/neu0000371.
    PubMed     Text format     Abstract available


    Neurosci Lett

  27. WANG X, Zhang J, Yuan Y, Li T, et al
    Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Neurosci Lett. 2017;653:202-207.
    PubMed     Text format     Abstract available

  28. SHIN JH, Shin SA, Lee JY, Nam H, et al
    Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Neurosci Lett. 2017;653:250-257.
    PubMed     Text format     Abstract available


    PLoS One

  29. SAMOTUS O, Lee J, Jog M
    Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
    PLoS One. 2017;12:e0178670.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: